1. HBW Insight
  2. >>Beauty
  3. >>Business
  4. >>Earnings

Listerine, Tylenol Push J&J Consumer Health To 2020 Finish Line Against Pandemic Weight

 
• By Eileen Francis

Listerine mouthwash drove J&J’s oral care sales up 11.4% in the fourth quarter. Tylenol for adults was the star of its OTC drug business but weakness of children’s Tylenol products and other OTCs led to flat sales.

4th quarter computer key on key board

Listerine mouthwash and wound-care products continued to drive Johnson & Johnson’s consumer health business sales as 2020 ended and the results were tempered by lower sales of most OTC drugs as pandemic lockdowns have led to a weak cold and flu season.

Worldwide consumer health sales totaled $3.6bn in the fourth quarter, up 1.4% on a reported basis. In the US, sales climbed 2.7% to $1.51bn; international sales inched up 0.5% to $2

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

More from Business

P&G: Innovation, Pricing ‘Short-Term Levers’ For Tariffs Adding Up To $1.5Bn In Costs Annually

 
• By Eileen Francis

The Procter & Gamble Company is working to mitigate the impact of tariffs, which will add up to $1.5bn in costs annually. The firm has lowered its fiscal 2025 outlook.

NAD Refers Men’s Hair Color Brand To FTC For Non-Compliance With Fast-Track SWIFT Decision

 
• By Eileen Francis

Plano, Texas-based Simpler Hair Color Inc. may face FTC enforcement action after it failed to comply with the National Advertising Division’s recommendations it discontinue the claim, “Rated #1 Men’s Hair Color,” associated with a consumer review website.

Beiersdorf Repositioning In China Will Get Boost From Thiamidol Launch

 
• By Eileen Francis

Beiersdorf AG hit some initial bumps with a repositioning of its business in China, but the firm is optimistic about the rollout of Thiamidol Skin Care In 2026.